<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59602</article-id><article-id pub-id-type="doi">10.17816/0869-2106-2020-26-5-292-297</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Clinical medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клиническая медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Uric acid as a prognostic marker in elderly patients with an exacerbation of coronary artery disease</article-title><trans-title-group xml:lang="ru"><trans-title>Мочевая кислота как прогностический маркер у больных пожилого возраста, перенесших обострение ишемической болезни сердца</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8377-1350</contrib-id><name-alternatives><name xml:lang="en"><surname>Zubova</surname><given-names>Ekaterina A.</given-names></name><name xml:lang="ru"><surname>Зубова</surname><given-names>Екатерина Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>zubova.katerinka@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Brazhnik</surname><given-names>Victoria A.</given-names></name><name xml:lang="ru"><surname>Бражник</surname><given-names>Виктория Алексеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>vabrahznik@bk.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Minushkina</surname><given-names>Larisa O.</given-names></name><name xml:lang="ru"><surname>Минушкина</surname><given-names>Лариса Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>minushkina@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8867-117X</contrib-id><name-alternatives><name xml:lang="en"><surname>Averkova</surname><given-names>Anastasia О.</given-names></name><name xml:lang="ru"><surname>Аверкова</surname><given-names>Анастасия Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>avek@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7065-2045</contrib-id><name-alternatives><name xml:lang="en"><surname>Zateyshchikov</surname><given-names>Dmitry A.</given-names></name><name xml:lang="ru"><surname>Затейщиков</surname><given-names>Дмитрий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc, Professor</p></bio><bio xml:lang="ru"><p>д. м. н., профессор</p></bio><email>dz@bk.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">City Сlinical Hospital № 51</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Городская клиническая больница № 51 Департамента здравоохранения г. Москвы»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Central State Medical Academy</institution></aff><aff><institution xml:lang="ru">ФГБОУ ДПО «Центральная государственная медицинская академия» Управления делами Президента РФ</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">M.V. Lomonosov Moscow Sstate Uuniversity</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-10-28" publication-format="electronic"><day>28</day><month>10</month><year>2020</year></pub-date><volume>26</volume><issue>5</issue><issue-title xml:lang="ru"/><fpage>292</fpage><lpage>297</lpage><history><date date-type="received" iso-8601-date="2021-01-28"><day>28</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-01-28"><day>28</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Эко-Вектор"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2024-01-28"/></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/59602">https://medjrf.com/0869-2106/article/view/59602</self-uri><abstract xml:lang="en"><p>The search for causal factors that can influence the prognosis after an acute coronary syndrome in elderly patients is a critical task. This study aimed to assess the correlation between increased uric acid levels with the incidence of adverse outcomes in patients over 75 years of age with history of acute coronary syndrome. Medical Records of 343 patients over 75 years old with history of acute coronary syndrome were retrospectively reviewed. Clinical characteristics and laboratory data upon admission, whether deceased or survived, were also analyzed. When carrying out multivariate analysis, following factors independently associated with total mortality were analyzed: aortic stenosis, atrial fibrillation, hyperglycemia, and acute heart failure at the moment of the index event, hyperuricemia, and percutaneous coronary intervention at the time of hospitalization caused by the index event. Thus, an increase in the level of uric acid is an independent predictor of lethality in the senior age group patients.</p></abstract><trans-abstract xml:lang="ru"><p>Поиск факторов, способных оказать влияние на прогноз после перенесенного острого коронарного синдрома у пациентов пожилой группы, является актуальной задачей. Целью данного исследования стала оценка ассоциации повышения уровня мочевой кислоты с частотой неблагоприятных исходов у пациентов старше 75 лет, перенесших острый коронарный синдром. Проанализированы данные 343 пациентов c острым коронарным синдромом старше 75 лет. Проанализированы клинические характеристики и лабораторные данные при поступлении умерших и выживших больных. При проведении многофакторного анализа факторами, независимо ассоциированными с общей смертностью, оказались наличие у больных аортального стеноза, мерцательной аритмии, гипергликемии и острой сердечной недостаточности при индексном событии, гиперурикемия, чрескожное коронарное вмешательство при индексной госпитализации. Таким образом, повышение уровня мочевой кислоты является независимым предиктором смерти пациентов старшей возрастной группы.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>uric acid</kwd><kwd>adverse outcomes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>мочевая кислота</kwd><kwd>неблагоприятные исходы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Uchmanowicz I, Lisiak M, Wleklik M, Gurowiec P, Kałużna-Oleksy M, et al. The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome. Clin Interv Aging. 2019;14:805-816. doi: 10.2147/CIA.S204121.</mixed-citation><mixed-citation xml:lang="ru">Uchmanowicz I., Lisiak M., Wleklik M., Gurowiec P., Kałużna-Oleksy M. The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome. Clin. Interv. Aging. 2019;14:805-16. Doi: 10.2147/CIA.S204121.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Eckner D, Popp S, Wicklein S, Pauschinger M. Acute coronary syndrome in older people. Z Gerontol Geriatr. 2018;51(4):461-475. (In German). doi: 10.1007/s00391-018-1411-y.</mixed-citation><mixed-citation xml:lang="ru">Eckner D., Popp S., Wicklein S., Pauschinger M. Acute coronary syndrome in older people. Z. Gerontol. Geriatri. 2018;51(4):461-75. (in German) Doi: 10.1007/s00391-018-1411-y.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol. 2014;29(6):999-1008. doi: 10.1007/s00467-013-2549-x.</mixed-citation><mixed-citation xml:lang="ru">Fathallah-Shaykh S.A., Cramer M.T. Uric acid and the kidney. Pediatr. Nephrol. 2014;29(6):999-1008. Doi: 10.1007/s00467-013-2549-x.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Sharaf El Din UA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J Adv Res. 2017;8(5):537-548. doi: 10.1016/j.jare.2016.11.004.</mixed-citation><mixed-citation xml:lang="ru">Sharaf El Din U.A., Salem M.M., Abdulazim D.O. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J. Adv. Res. 2017;8(5):537-48. Doi: 10.1016/j.jare.2016.11.004.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Jayashankar CA, Andrews HP, Vijayasarathi, Pinnelli VB, Shashidharan B, Nithin Kumar HN, Vemulapalli S. Serum uric acid and low-density lipoprotein cholesterol levels are independent predictors of coronary artery disease in Asian Indian patients with type 2 diabetes mellitus. J Nat Sci Biol Med. 2016;7(2):161-165. doi: 10.4103/0976-9668.184703.</mixed-citation><mixed-citation xml:lang="ru">Jayashankar C.A., Andrews H.P., Vijayasarathi, Pinnelli V.B., Shashidharan B., Nithin Kumar H.N., Vemulapalli S. Serum uric acid and low-density lipoprotein cholesterol levels are independent predictors of coronary artery disease in Asian Indian patients with type 2 diabetes mellitus. J. Nat. Sci. Biol. Med. 2016;7(2):161-5. Doi: 10.4103/0976-9668.184703.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Tscharre M, Herman R, Rohla M, Hauser C, Farhan S, Freynhofer MK, et al. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173-179. doi: 10.1016/j.atherosclerosis.2018.02.003.</mixed-citation><mixed-citation xml:lang="ru">Tscharre M., Herman R., Rohla M., Hauser C., Farhan S., Freynhofer M.K., et al. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173-9. Doi: 10.1016/j.atherosclerosis.2018.02.003.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Magnoni M, Berteotti M, Ceriotti F, Mallia V, Vergani V, Peretto G, et al. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. Int J Cardiol. 2017;240:25-29. doi: 10.1016/j.ijcard.2017.04.027.</mixed-citation><mixed-citation xml:lang="ru">Magnoni M., Berteotti M., Ceriotti F., Mallia V., Vergani V., Peretto G., et al. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. Int. J. Cardiol. 2017;240:25-9. Doi: 10.1016/j.ijcard.2017.04.027.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Averkova AO, Brazhnik VA, Koroleva OS, Zubova EA, Khasanov NR, Chichkov YuM, et al. Acute coronary syndrome in young patients with familial hyperchoolesterolemia based on the results of Oracul II observation trial. Medical news of the North Caucasus. 2017;12(1):5-8. (in Russ). doi: 10.14300/mnnc.2017.12001.</mixed-citation><mixed-citation xml:lang="ru">Аверкова А.О., Бражник В.А., Королева О.С., Зубова Е.А., Хасанов Н.Р., Чичков Ю.М. и др. Особенности течения острого коронарного синдрома у молодых больных с гиперлипидемией по данным наблюдательного проекта ОРАКУЛ II. Медицинский вестник Северного Кавказа. 2017;12(1):5-8.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Pagidipati NJ, Hess CN, Clare RM, Akerblom A, Tricoci P, Wojdyla D, et al. An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. Am Heart J. 2017;187:53-61. doi: 10.1016/j.ahj.2017.02.023.</mixed-citation><mixed-citation xml:lang="ru">Pagidipati N.J., Hess C.N., Clare R.M., Akerblom A., Tricoci P., Wojdyla D., et al. An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. Am. Heart J. 2017;187:53-61. Doi: 10.1016/j.ahj.2017.02.023.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Guo G, Huang Z, Wang S, Chen X. Sex differences in uric acid and NT-pro BNP assessments during coronary severity. Medicine (Baltimore). 2020;99(15):e19653. doi: 10.1097/MD.0000000000019653.</mixed-citation><mixed-citation xml:lang="ru">Guo G., Huang Z., Wang S., Chen X. Sex differences in uric acid and NT-pro BNP assessments during coronary severity. Medicine (Baltimore). 2020;99(15):e19653. Doi: 10.1097/MD.0000000000019653.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of elevated serum uric acid level to endothelial dysfunction in patients with acute coronary syndrome. J Atheroscler Thromb. 2019;26(4):362-367. doi: 10.5551/jat.45179.</mixed-citation><mixed-citation xml:lang="ru">Saito Y., Kitahara H., Nakayama T., Fujimoto Y., Kobayashi Y. Relation of elevated serum uric acid level to endothelial dysfunction in patients with acute coronary syndrome. J. Atheroscler. Thromb. 2019;26(4):362-7. Doi: 10.5551/jat.45179.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Kobayashi N, Hata N, Tsurumi M, Shibata Y, Okazaki H, Shirakabe A, et al. Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to serum uric acid levels in patients with acute coronary syndrome. Am J Cardiol. 2018;122(1):17-25. doi: 10.1016/j.amjcard.2018.03.022.</mixed-citation><mixed-citation xml:lang="ru">Kobayashi N., Hata N., Tsurumi M., Shibata Y., Okazaki H., Shirakabe A., Shibata Y, Okazaki H, Shirakabe A, et al. Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to serum uric acid levels in patients with acute coronary syndrome. Am. J. Cardiol. 2018;122(1):17-25. Doi: 10.1016/j.amjcard.2018.03.022.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang D, Zhang R, Wang N, Lin L, Yu B. Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3-vessel optical coherence tomography study. Biomed Res Int. 2018;2018:7919165. doi: 10.1155/2018/7919165.</mixed-citation><mixed-citation xml:lang="ru">Zhang D., Zhang R., Wang N., Lin L., Yu B. Correlation of Serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3-vessel optical coherence tomography study. Biomed. Res. Int. 2018;2018:7919165. Doi: 10.1155/2018/7919165.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Saito Y, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation of lipid content of coronary plaque to level of serum uric acid. Am J Cardiol. 2015;116(9):1346-1350. doi: 10.1016/j.amjcard.2015.07.059.</mixed-citation><mixed-citation xml:lang="ru">Saito Y., Nakayama T., Sugimoto K., Fujimoto Y., Kobayashi Y. Relation of lipid content of coronary plaque to level of serum uric acid. Am. J. Cardiol. 2015;116(9):1346-50. Doi: 10.1016/j.amjcard.2015.07.059.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Spahic E, Hasic S, Kiseljakovic E, Resić H, Kulić M. Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes. Med Glas (Zenica). 2015;12(2):128-132. Doi: 10.17392/821</mixed-citation><mixed-citation xml:lang="ru">Spahić E., Hasić S., Kiseljaković E., Resić H., Kulić M. Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes. Med. Glas. (Zenica). 2015;12(2):128-32. Doi: 10.17392/821-15.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Desai R, Parekh T, Goyal H, Fong HK, Zalavadia D, Damarlapally N, et al. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: insights from the national inpatient sample. World J Cardiol. 2019;11(5):137-148. doi: 10.4330/wjc.v11.i5.137.</mixed-citation><mixed-citation xml:lang="ru">Desai R., Parekh T., Goyal H., Fong H.K., Zalavadia D., Damarlapally N., et al. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: insights from the national inpatient sample. World J. Cardiol. 2019;11(5):137-48. Doi: 10.4330/wjc.v11.i5.137.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Tai S, Li X, Zhu Z, Tang L, Yang H, Fu L, et al. Hyperuricemia is a risk factor for one-year overall survival in elderly female patients with acute coronary syndrome. Cardiovasc Therap. 2020;2020:2615147. doi: 10.1155/2020/2615147.</mixed-citation><mixed-citation xml:lang="ru">Tai S., Li X., Zhu Z., Tang L., Yang H., Fu L., et al. Hyperuricemia is a risk factor for one-year overall survival in elderly female patients with acute coronary syndrome. Cardiovasc. Ther. 2020;2020:2615147. Doi: 10.1155/2020/2615147.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
